KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Idexx Laboratories (IDXX) Interest Expenses (2016 - 2025)

Idexx Laboratories has reported Interest Expenses over the past 17 years, most recently at $9.2 million for Q4 2025.

  • Quarterly results put Interest Expenses at $9.2 million for Q4 2025, up 22.83% from a year ago — trailing twelve months through Dec 2025 was $38.9 million (up 24.51% YoY), and the annual figure for FY2025 was $38.9 million, up 24.51%.
  • Interest Expenses for Q4 2025 was $9.2 million at Idexx Laboratories, down from $10.7 million in the prior quarter.
  • Over the last five years, Interest Expenses for IDXX hit a ceiling of $13.5 million in Q4 2022 and a floor of $7.0 million in Q1 2022.
  • Median Interest Expenses over the past 5 years was $8.2 million (2022), compared with a mean of $9.1 million.
  • Biggest five-year swings in Interest Expenses: skyrocketed 87.64% in 2023 and later crashed 39.73% in 2024.
  • Idexx Laboratories' Interest Expenses stood at $7.5 million in 2021, then skyrocketed by 81.18% to $13.5 million in 2022, then plummeted by 31.61% to $9.3 million in 2023, then decreased by 19.07% to $7.5 million in 2024, then grew by 22.83% to $9.2 million in 2025.
  • The last three reported values for Interest Expenses were $9.2 million (Q4 2025), $10.7 million (Q3 2025), and $11.3 million (Q2 2025) per Business Quant data.